deferasirox has been researched along with hydrazine in 4 studies
Studies (deferasirox) | Trials (deferasirox) | Recent Studies (post-2010) (deferasirox) | Studies (hydrazine) | Trials (hydrazine) | Recent Studies (post-2010) (hydrazine) |
---|---|---|---|---|---|
832 | 136 | 572 | 12,034 | 330 | 3,193 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Argenziano, M; Casale, M; Perrotta, S; Punzo, F; Rossi, F; Tortora, C | 1 |
Andreani, G; Cilloni, D; De Gobbi, M; Dragani, M; Saglio, G | 1 |
Argenziano, M; Di Martino, M; Di Paola, A; Di Pinto, D; Perrotta, S; Pota, E; Punzo, F; Rossi, F; Tortora, C | 1 |
Fu, R; Huang, L; Liu, C; Liu, Z; Tian, M | 1 |
1 review(s) available for deferasirox and hydrazine
Article | Year |
---|---|
Synergistic effect of eltrombopag and deferasirox in aplastic anemia: a clinical case and review of the literature.
Topics: Anemia, Aplastic; Benzoates; Deferasirox; Humans; Hydrazines; Pyrazoles | 2020 |
3 other study(ies) available for deferasirox and hydrazine
Article | Year |
---|---|
Iron chelating properties of Eltrombopag: Investigating its role in thalassemia-induced osteoporosis.
Topics: Adult; Benzoates; Blood Transfusion; Bone and Bones; Cell Differentiation; Deferasirox; Drug Evaluation; Female; Ferritins; Healthy Volunteers; Humans; Hydrazines; Iron; Iron Chelating Agents; Iron Overload; Leukocytes, Mononuclear; Osteoclasts; Osteoporosis; Primary Cell Culture; Pyrazoles; Receptors, Thrombopoietin; Thalassemia; Transfusion Reaction | 2018 |
Effects of Iron Chelation in Osteosarcoma.
Topics: Apoptosis; Benzoates; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deferasirox; Drug Therapy, Combination; Humans; Hydrazines; Iron Chelating Agents; Osteosarcoma; Pyrazoles; Treatment Outcome | 2021 |
Deferasirox combination with eltrombopag shows anti-myelodysplastic syndrome effects by enhancing iron deprivation-related apoptosis.
Topics: Apoptosis; Benzoates; Deferasirox; Humans; Hydrazines; Iron; Iron Chelating Agents; Myelodysplastic Syndromes; Pyrazoles; Thrombocytopenia | 2022 |